Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Taiho Pharmaceutical licences lung cancer drug to Cullinan Oncology

pharmaceutical-technologyFebruary 20, 2019

Tag: Taiho Pharmaceutical , EGFR , Cullinan Oncology , TAS6417

PharmaSources Customer Service